Jasper Hellweg
Stock Analyst at Argus Research
(4.27)
# 1,456
Out of 5,133 analysts
239
Total ratings
56.8%
Success rate
8.1%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Reiterated: Buy | $460 → $515 | $465.67 | +10.59% | 8 | Nov 12, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | $120 → $190 | $168.08 | +13.04% | 8 | Nov 11, 2026 | |
| FISV Fiserv | Upgraded: Buy | n/a | $63.78 | - | 5 | Nov 4, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,550 | $1,443.50 | +7.38% | 5 | Oct 30, 2026 | |
| BIIB Biogen | Upgraded: Buy | $280 | $253.40 | +10.50% | 7 | Oct 29, 2026 | |
| REGN Regeneron Pharmaceuticals | Upgraded: Buy | $850 | $955.47 | -11.04% | 14 | Sep 30, 2026 | |
| VTRS Viatris | Reiterated: Buy | $20 | $20.82 | -3.94% | 5 | Sep 8, 2026 | |
| ILMN Illumina | Reiterated: Buy | $100 → $235 | $207.01 | +13.52% | 13 | Sep 2, 2026 | |
| MRNA Moderna | Upgraded: Buy | $180 | $223.37 | -19.42% | 15 | Aug 27, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $145 → $170 | $147.76 | +15.05% | 7 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $41.63 | - | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $75 | $63.43 | +18.24% | 5 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $170 | $160.50 | +5.92% | 3 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 71.00 | CHF 61.36 | +15.71% | 5 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $26.78 | - | 7 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $50.45 | - | 2 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $83.82 | - | 12 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 → $250 | $295.03 | -15.26% | 5 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $55 | $60.30 | -8.79% | 3 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $345 → $560 | $591.17 | -5.27% | 11 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $25.81 | n/a | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $60 | $48.37 | n/a | 3 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $465 → $550 | $538.60 | n/a | 11 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $125 | $126.70 | n/a | 8 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $70 | $120.97 | n/a | 6 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $26 | $5.00 | n/a | 5 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $285 → $225 | $188.12 | n/a | 6 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $370.48 | n/a | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 → $165 | $259.60 | n/a | 6 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $475 → $500 | $429.69 | n/a | 5 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 → $290 | $265.12 | n/a | 5 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 → $275 | $499.05 | n/a | 6 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $50 | $44.34 | n/a | 3 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.79 | n/a | 5 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 → $135 | $98.61 | n/a | 5 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $16.24 | n/a | 3 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $308.79 | n/a | 4 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $46.59 | n/a | 1 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $19.15 | n/a | 2 | Aug 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $171.39 | n/a | 1 | Aug 31, 2016 |
Amgen
Nov 12, 2026
Reiterated: Buy
Price Target: $460 → $515
Current: $465.67
Upside: +10.59%
Gilead Sciences
Nov 11, 2026
Reiterated: Buy
Price Target: $120 → $190
Current: $168.08
Upside: +13.04%
Fiserv
Nov 4, 2026
Upgraded: Buy
Price Target: n/a
Current: $63.78
Upside: -
Eli Lilly and Company
Oct 30, 2026
Reiterated: Buy
Price Target: $1,550
Current: $1,443.50
Upside: +7.38%
Biogen
Oct 29, 2026
Upgraded: Buy
Price Target: $280
Current: $253.40
Upside: +10.50%
Regeneron Pharmaceuticals
Sep 30, 2026
Upgraded: Buy
Price Target: $850
Current: $955.47
Upside: -11.04%
Viatris
Sep 8, 2026
Reiterated: Buy
Price Target: $20
Current: $20.82
Upside: -3.94%
Illumina
Sep 2, 2026
Reiterated: Buy
Price Target: $100 → $235
Current: $207.01
Upside: +13.52%
Moderna
Aug 27, 2026
Upgraded: Buy
Price Target: $180
Current: $223.37
Upside: -19.42%
Merck & Co.
Aug 24, 2026
Reiterated: Buy
Price Target: $145 → $170
Current: $147.76
Upside: +15.05%
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $41.63
Upside: -
Aug 4, 2026
Upgraded: Buy
Price Target: $75
Current: $63.43
Upside: +18.24%
Jul 24, 2026
Reiterated: Buy
Price Target: $160 → $170
Current: $160.50
Upside: +5.92%
Jul 1, 2026
Reiterated: Buy
Price Target: CHF 71.00
Current: CHF 61.36
Upside: +15.71%
Jun 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $26.78
Upside: -
Jun 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $50.45
Upside: -
May 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $83.82
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: $220 → $250
Current: $295.03
Upside: -15.26%
Apr 6, 2026
Upgraded: Buy
Price Target: $55
Current: $60.30
Upside: -8.79%
Mar 3, 2026
Rated: Buy
Price Target: $345 → $560
Current: $591.17
Upside: -5.27%
Feb 24, 2025
Upgraded: Buy
Price Target: $40
Current: $25.81
Upside: n/a
Jul 26, 2024
Reiterated: Buy
Price Target: $55 → $60
Current: $48.37
Upside: n/a
Jun 17, 2024
Reiterated: Buy
Price Target: $465 → $550
Current: $538.60
Upside: n/a
Apr 29, 2024
Reiterated: Buy
Price Target: $105 → $125
Current: $126.70
Upside: n/a
Apr 25, 2024
Reiterated: Buy
Price Target: $90 → $70
Current: $120.97
Upside: n/a
Dec 7, 2022
Upgraded: Buy
Price Target: $26
Current: $5.00
Upside: n/a
Oct 24, 2022
Reiterated: Buy
Price Target: $285 → $225
Current: $188.12
Upside: n/a
Sep 19, 2022
Downgraded: Hold
Price Target: n/a
Current: $370.48
Upside: n/a
Aug 17, 2022
Reiterated: Buy
Price Target: $135 → $165
Current: $259.60
Upside: n/a
Feb 7, 2022
Reiterated: Buy
Price Target: $475 → $500
Current: $429.69
Upside: n/a
Sep 10, 2021
Reiterated: Buy
Price Target: $260 → $290
Current: $265.12
Upside: n/a
Aug 2, 2021
Reiterated: Buy
Price Target: $195 → $275
Current: $499.05
Upside: n/a
Jun 7, 2021
Reiterated: Buy
Price Target: $43 → $50
Current: $44.34
Upside: n/a
May 5, 2021
Downgraded: Hold
Price Target: n/a
Current: $5.79
Upside: n/a
May 3, 2021
Reiterated: Buy
Price Target: $95 → $135
Current: $98.61
Upside: n/a
Apr 17, 2020
Downgraded: Hold
Price Target: n/a
Current: $16.24
Upside: n/a
Mar 24, 2020
Downgraded: Hold
Price Target: n/a
Current: $308.79
Upside: n/a
Oct 30, 2019
Downgraded: Hold
Price Target: n/a
Current: $46.59
Upside: n/a
Aug 15, 2019
Upgraded: Buy
Price Target: $40
Current: $19.15
Upside: n/a
Aug 31, 2016
Downgraded: Hold
Price Target: n/a
Current: $171.39
Upside: n/a